M&A
-
Getty Images/Staff via Getty Images
Integer sells non-medical business for $50M
After making nearly $550 million worth of acquisitions in the past few years, the medical device contract manufacturer will use proceeds from the sale to pay down debt.
By Susan Kelly • Oct. 2, 2024 -
Mario Tama / Staff via Getty Images
What’s next at Masimo after CEO Kiani’s exit?
Investors are waiting to learn the next steps for the patient monitoring company after a hard-fought proxy battle, including how a separation of its consumer business could play out.
By Susan Kelly • Sept. 30, 2024 -
Getty Images via Getty Images
Stryker adds devices to remove brain tumors, clots with Nico buy
Nico sells devices for navigating through the brain, visualizing the organ, removing tumors and clots and collecting tissue.
By Nick Paul Taylor • Sept. 23, 2024 -
Courtesy of BusinessWire/Masimo
Masimo proxy fight nears end as shareholder vote looms
Chairman and CEO Joe Kiani’s board seat is on the line at today's shareholder meeting.
By Susan Kelly • Sept. 19, 2024 -
Courtesy of Cook Medical
Merit Medical inks $210M takeover of Cook’s lead management business
Merit predicts the portfolio, which includes devices used in procedures to remove or replace heart rhythm device leads, will add $40 million a year to its sales.
By Nick Paul Taylor • Sept. 18, 2024 -
Scott Olson via Getty Images
Bausch + Lomb considers sale: FT
Private equity could be “the most likely” buyer of the eye care business, analysts wrote.
By Elise Reuter • Sept. 16, 2024 -
Courtesy of Boston Scientific
Boston Scientific closes Silk Road Medical acquisition
Completion of the purchase comes three months after the companies announced the deal, and after Boston Scientific resubmitted its merger filing to give the FTC more review time.
By Ricky Zipp • Updated Sept. 17, 2024 -
Courtesy of Insightec
Medtech venture investment recovery continues, but startup M&A remains limited: Pitchbook
Acquisitions of late-stage VC startups have been rare, a fact Pitchbook attributed to “ongoing price gaps between buyers and sellers.”
By Nick Paul Taylor • Sept. 4, 2024 -
Courtesy of Grail
Illumina avoids fine for Grail purchase in European court victory
Illumina will avoid a penalty of 432 million euros after a court ruled the European Commission did not have jurisdiction to challenge the company’s Grail acquisition.
By Susan Kelly • Sept. 3, 2024 -
Retrieved from UFP Technologies on August 27, 2024
UFP to buy device component maker AQF Medical, extending deal spree
AQF makes foam and thermoplastic components for use in medical devices and packaging.
By Nick Paul Taylor • Aug. 28, 2024 -
Courtesy of Siemens Healthineers
Siemens Healthineers to grow PET imaging with purchase of Novartis assets
Siemens will pay 200 million euros for the manufacturing and distribution network of Novartis’ radiopharmaceutical molecular imaging business.
By Nick Paul Taylor • Aug. 27, 2024 -
Courtesy of Getinge
Getinge to buy Paragonix organ-preserving tech for up to $477M
Getinge will pay $253 million in cash at closing, with additional payments expected to be made between 2024 and 2026 if certain milestones are met.
By Ricky Zipp • Aug. 23, 2024 -
Courtesy of Quest Diagnostics
Quest inks deal for University Hospitals’ outreach lab services
The deal continues Quest’s expansion in Ohio and extends a string of acquisitions that began in May.
By Nick Paul Taylor • Aug. 23, 2024 -
Retrieved from Stryker on August 23, 2024
Stryker to add back pain treatment with Vertos Medical buy
Stryker’s latest purchase comes amid a pickup in medtech M&A, with Johnson & Johnson, Boston Scientific and Edwards Lifesciences all active this year.
By Susan Kelly • Aug. 23, 2024 -
Avosb via Getty Images
Zoll to buy Vyaire’s ventilator business with $37M auction bid
Vyaire Medical held a virtual auction of assets after filing for Chapter 11 bankruptcy protection in June.
By Nick Paul Taylor • Aug. 21, 2024 -
Retrieved from Masimo on August 20, 2024
Masimo’s consumer audio brands attract more suitors
Negotiations with a potential joint venture partner will continue while Masimo initiates discussions with new parties that have expressed interest in the consumer audio business.
By Susan Kelly • Aug. 21, 2024 -
Permission granted by Johnson & Johnson
J&J to buy heart failure implant maker V-Wave for up to $1.7B
J&J has agreed to pay $600 million upfront for the private company as it works to expand its portfolio of cardiovascular devices.
By Susan Kelly • Aug. 20, 2024 -
Courtesy of DuPont de Nemours.
DuPont acquires Donatelle Plastics for $313M
The acquisition of the medical device contract manufacturer comes as DuPont prioritizes expansion in the healthcare sector.
By Sara Samora • Aug. 19, 2024 -
Edwards continues M&A spree with Genesis’ TAVR tech
Edwards, which has made a series of acquisitions in recent months, is also investing $25 million in Singapore-based Genesis Medtech.
By Susan Kelly • Aug. 19, 2024 -
Courtesy of Boston Scientific
Boston Scientific resubmits Silk Road merger filing, giving FTC more review time
A Boston Scientific spokesperson said the company still expects to close its $1.26 billion purchase of Silk Road Medical in the second half of the year.
By Ricky Zipp • Aug. 16, 2024 -
Permission granted by Neuronetics
Neuronetics inks Greenbrook merger to acquire treatment centers
William Blair analysts said the deal changes Neuronetics’ profile “from device-centric to a device-service business operating brick-and-mortar facilities.”
By Nick Paul Taylor • Aug. 15, 2024 -
Tim Boyle via Getty Images
Baxter agrees to sell kidney care unit to Carlyle for $3.8B
Selling the business, called Vantive, rather than spinning it off, should maximize shareholder value and give Baxter more flexibility to pursue other growth opportunities, the company said.
By Susan Kelly • Aug. 13, 2024 -
Retrieved from Care.ai on August 12, 2024
Stryker to buy smart hospital technology firm Care.ai
The deal comes shortly after Stryker CEO Kevin Lobo told investors to expect a “very active deal pipeline” for the second half of 2024.
By Elise Reuter • Aug. 12, 2024 -
Courtesy of 23andMe
23andMe board rejects CEO Wojcicki’s take-private proposal
A special committee of the board said the proposal offers no premium to 23andMe’s stock price, and with a lack of committed financing, is “insufficient.”
By Elise Reuter • Aug. 2, 2024 -
Brad Barket via Getty Images
23andMe CEO proposes to take company private
Anne Wojcicki, who co-founded 23andMe, would pay 40 cents per share to buy the DNA testing company, which has been trading under $1 for nearly a year.
By Elise Reuter • Aug. 1, 2024
